Mohammed Al Rubaei: Where Do I Start When Evaluating a Patient With Suspected Hemolysis?
Mohammed Al Rubaei, Internal Medicine Specialist at Sheikh Shakhbout Medical City – SSMC, shared on LinkedIn:
”Not every anemia is due to blood loss or decreased production.
Sometimes the problem is destruction.
Missing hemolytic anemia can delay life-saving treatment and expose patients to devastating complications such as acute kidney injury, thrombosis, organ failure, and even death.
Over the years, I found that many trainees struggle with one question:
‘Where do I start when evaluating a patient with suspected hemolysis?’
To simplify this, I developed a practical bedside approach that focuses on four key steps:
- Confirm hemolysis
- Identify the mechanism
- Determine the underlying cause
- Assess severity and urgency
Think hemolysis when anemia is accompanied by:
- Reticulocytosis
- Elevated LDH
- Elevated indirect bilirubin
- Low haptoglobin
- Abnormal peripheral smear findings
Never overlook critical diagnoses such as:
- Autoimmune hemolytic anemia (AIHA)
- TTP/HUS
- G6PD-related hemolysis
- Drug-induced hemolysis
- Mechanical valve hemolysis
- Severe infections including malaria
Red flags requiring urgent action:
- Hemodynamic instability
- Neurological symptoms
- Acute kidney injury
- Chest pain or myocardial ischemia
- Rapid hemoglobin decline
A well-performed history, peripheral smear, and DAT (Coombs test) often provide the biggest diagnostic clues.
This infographic focuses on the initial evaluation and early diagnostic approach to hemolytic anemia, particularly in acute care settings.
It represents the first step of a larger project.
Future versions will explore detailed diagnostic algorithms and cause-specific workups to help clinicians progress from recognizing hemolysis to identifying the underlying etiology and guiding definitive management.
I welcome feedback, suggestions, and shared experiences from colleagues.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz IrawanÖ‰ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session